Literature DB >> 1797322

Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations.

X Norel1, C Labat, P J Gardiner, C Brink.   

Abstract

1. The thromboxane-mimetic, U46619, was a more potent contractile agonist than prostaglandin D2 (PGD2), PGF2 alpha or histamine in human isolated bronchial and pulmonary arterial muscle preparations. 2. Human isolated proximal bronchial muscles were less sensitive to contractile agents than distal bronchial preparations. However, the former tissues developed a greater contractile force (Emax) when compared with results obtained in the latter tissues. 3. BAY u3405 attenuated the contractions induced by U46619, PGF2 alpha and PGD2 in both human isolated bronchial and pulmonary arterial muscle preparations. 4. BAY u3405 did not alter histamine concentration-effect curves nor the relaxation induced by Butaprost (TR4979) in human isolated bronchial muscle preparations. In addition BAY u3405 did not modify the relaxation induced by PGI2 in isolated pulmonary arterial muscle preparations. 5. The contractions induced by different prostaglandins were blocked by BAY u3405, suggesting a common functional site for these agents found both on human bronchial and pulmonary arterial muscles.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1797322      PMCID: PMC1908232          DOI: 10.1111/j.1476-5381.1991.tb12474.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2.

Authors:  R T Brittain; L Boutal; M C Carter; R A Coleman; E W Collington; H P Geisow; P Hallett; E J Hornby; P P Humphrey; D Jack
Journal:  Circulation       Date:  1985-12       Impact factor: 29.690

2.  Characterisation of the prostanoid receptors mediating contraction of guinea-pig isolated trachea.

Authors:  R A Coleman; I Kennedy
Journal:  Prostaglandins       Date:  1985-03

3.  Contractile effects of histamine in large and small respiratory airways.

Authors:  G A Persson; M Ekman
Journal:  Agents Actions       Date:  1976-07

4.  Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors.

Authors:  R A Coleman; R L Sheldrick
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

5.  Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea.

Authors:  R L Jones; V Peesapati; N H Wilson
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

6.  Histamine contraction of isolated human airway muscle preparations: role of prostaglandins.

Authors:  I Haye-Legrand; J Cerrina; B Raffestin; C Labat; C Boullet; A Bayol; J Benveniste; C Brink
Journal:  J Pharmacol Exp Ther       Date:  1986-11       Impact factor: 4.030

7.  Studies on the characterisation of prostanoid receptors: a proposed classification.

Authors:  I Kennedy; R A Coleman; P P Humphrey; G P Levy; P Lumley
Journal:  Prostaglandins       Date:  1982-11

8.  Characterization of contractile prostanoid receptors on human airway smooth muscle.

Authors:  C L Armour; P R Johnson; M L Alfredson; J L Black
Journal:  Eur J Pharmacol       Date:  1989-06-20       Impact factor: 4.432

9.  Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents.

Authors:  B Raffestin; J Cerrina; C Boullet; C Labat; J Benveniste; C Brink
Journal:  J Pharmacol Exp Ther       Date:  1985-04       Impact factor: 4.030

10.  GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.

Authors:  P Lumley; B P White; P P Humphrey
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

View more
  13 in total

1.  Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.

Authors:  A H Krauss; D F Woodward; L L Gibson; C E Protzman; L S Williams; R M Burk; T S Gac; M B Roof; F Abbas; K Marshall; J Senior
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

2.  Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.

Authors:  L Walch; V de Montpreville; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  Prostanoid receptors involved in the relaxation of human bronchial preparations.

Authors:  X Norel; L Walch; C Labat; J P Gascard; E Dulmet; C Brink
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  Prostanoid receptors involved in the relaxation of human pulmonary vessels.

Authors:  L Walch; C Labat; J P Gascard; V de Montpreville; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury.

Authors:  F Squadrito; M Ioculano; D Altavilla; B Zingarelli; P Canale; G M Campo; A Saitta; S Oriti; A Faggiotto; A P Caputi
Journal:  Agents Actions       Date:  1993-07

6.  The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations.

Authors:  S L Johnston; P G Bardin; J Harrison; W Ritter; J R Joubert; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

7.  Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype.

Authors:  N Foudi; L Kotelevets; L Louedec; G Leséche; D Henin; E Chastre; X Norel
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

8.  Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.

Authors:  Y M Qian; R L Jones; K M Chan; A I Stock; J K Ho
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

9.  Effects of beta 2-adrenoceptor agonists on anti-IgE-induced contraction and smooth muscle reactivity in human airways.

Authors:  I Gorenne; C Labat; X Norel; V De Montpreville; M C Guillet; I Cavero; C Brink
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

10.  Residential exposure to plasticizers and its possible role in the pathogenesis of asthma.

Authors:  L Oie; L G Hersoug; J O Madsen
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.